151 related articles for article (PubMed ID: 23321510)
1. Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group.
Behringer K; Müller H; Görgen H; Flechtner HH; Brillant C; Halbsguth TV; Thielen I; Eichenauer DA; Schober T; Nisters-Backes H; Fuchs M; Engert A; Borchmann P
Br J Cancer; 2013 Jan; 108(1):49-57. PubMed ID: 23321510
[TBL] [Abstract][Full Text] [Related]
2. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
[TBL] [Abstract][Full Text] [Related]
3. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
[TBL] [Abstract][Full Text] [Related]
4. Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.
Kreissl S; Müller H; Goergen H; Meissner J; Topp M; Sökler M; Markova J; Bernhard J; Greil R; von Tresckow B; Behringer K; Rüffer JU; Flechtner HH; Möstl M; Fuchs M; Engert A; Diehl V; Borchmann P
J Clin Oncol; 2020 Sep; 38(25):2839-2848. PubMed ID: 32574114
[TBL] [Abstract][Full Text] [Related]
5. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
Kreissl S; Mueller H; Goergen H; Mayer A; Brillant C; Behringer K; Halbsguth TV; Hitz F; Soekler M; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P;
Lancet Oncol; 2016 Oct; 17(10):1453-1462. PubMed ID: 27612583
[TBL] [Abstract][Full Text] [Related]
6. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
[TBL] [Abstract][Full Text] [Related]
7. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
Busson R; van der Kaaij M; Mounier N; Aleman BMP; Thiéblemont C; Stamatoullas A; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Kluin-Nelemans HC; Henry-Amar M
Health Qual Life Outcomes; 2019 Jul; 17(1):115. PubMed ID: 31266501
[TBL] [Abstract][Full Text] [Related]
8. The interplay between cancer-related fatigue and functional health in Hodgkin lymphoma survivors.
Stadtbaeumer N; Müller H; Goergen H; Kreissl S; Borchmann P; Mayer A
Health Psychol; 2020 Oct; 39(10):905-911. PubMed ID: 32496079
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.
Behringer K; Goergen H; Müller H; Thielen I; Brillant C; Kreissl S; Halbsguth TV; Meissner J; Greil R; Moosmann P; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2016 Dec; 34(36):4329-4337. PubMed ID: 27998235
[TBL] [Abstract][Full Text] [Related]
10. Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin's lymphoma: results from the randomized international GHSG HD18 trial.
Ferdinandus J; Müller H; Damaschin C; Jacob AS; Meissner J; Krasniqi F; Mey U; Schöndube D; Thiemer J; Mathas S; Zijlstra J; Greil R; Feuring-Buske M; Markova J; Rüffer JU; Kobe C; Eich HT; Baues C; Fuchs M; Borchmann P; Behringer K
Ann Oncol; 2024 Mar; 35(3):276-284. PubMed ID: 38061428
[TBL] [Abstract][Full Text] [Related]
11. Employment status and health related quality of life among Hodgkin-lymphoma survivors'- results based on data from a major treatment center in Hungary.
Magyari F; Kósa K; Berecz R; Illés A; Miltényi Z; Simon Z; Illés Á
Health Qual Life Outcomes; 2017 Sep; 15(1):180. PubMed ID: 28927453
[TBL] [Abstract][Full Text] [Related]
12. Association of social network and social support with health-related quality of life and fatigue in long-term survivors of Hodgkin lymphoma.
Soares A; Biasoli I; Scheliga A; Baptista RL; Brabo EP; Morais JC; Werneck GL; Spector N
Support Care Cancer; 2013 Aug; 21(8):2153-9. PubMed ID: 23475196
[TBL] [Abstract][Full Text] [Related]
13. The quality of life of long-term survivors of Hodgkin's disease.
van Tulder MW; Aaronson NK; Bruning PF
Ann Oncol; 1994 Feb; 5(2):153-8. PubMed ID: 8186158
[TBL] [Abstract][Full Text] [Related]
14. Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG).
Rüffer JU; Flechtner H; Tralls P; Josting A; Sieber M; Lathan B; Diehl V;
Eur J Cancer; 2003 Oct; 39(15):2179-86. PubMed ID: 14522376
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
16. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.
Oerlemans S; Mols F; Nijziel MR; Lybeert M; van de Poll-Franse LV
Ann Hematol; 2011 Sep; 90(9):993-1004. PubMed ID: 21670973
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease: quality of life in future trials.
Kaasa S; Knobel H; Loge JH; Hjermstad MJ
Ann Oncol; 1998; 9 Suppl 5():137-45. PubMed ID: 9926254
[TBL] [Abstract][Full Text] [Related]
18. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
Müller RP; Eich HT
Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
[TBL] [Abstract][Full Text] [Related]
19. Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy.
Brandt J; Dietrich S; Meissner J; Neben K; Ho AD; Witzens-Harig M
Leuk Lymphoma; 2010 Nov; 51(11):2012-20. PubMed ID: 20858092
[TBL] [Abstract][Full Text] [Related]
20. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
